The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IWWM-11 2022 | Recent updates from the ALPINE trial
In this video, Constantine Tam, MBBS (Hons), MD, FRACP, FRCPA, Alfred Health, Monash University, Melbourne, Australia, briefly shares some updates from the ALPINE trial (NCT03734016), highlighting the higher efficacy observed with the use of zanubrutinib compared to ibrutinib in patients with chronic lymphocytic leukemia (CLL). This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
